What You Should Know: – Abridge, a leader in generative AI for healthcare documentation forms a strategic collaboration with NVIDIA to leverage NVIDIA’s cutting-edge technology
What You Should Know: – A new survey by Carta Healthcare®, a company focused on harnessing the power of clinical data, sheds light on the
What You Should Know: Humana Inc. (NYSE: HUM) and DUOS, a technology-enabled service provider announces a new collaborative program to enhance the healthcare experience and improve health
What You Should Know: – Artera, a leading SaaS digital health provider, enhances its Artera Harmony platform with premium capabilities through Artera Referrals. This expansion aims to
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Intuitive Surgical has led the field of
Dive Brief: Deka Research & Development has received 510(k) clearance for the Twiist automated insulin delivery (AID) system, the company’s partner Sequel Med Tech said
Dive Brief: The Food and Drug Administration said Tuesday it has sent three warning letters related to its investigation into plastic syringes made in China. FDA
Researchers have developed a genetic test that can identify how patients with triple negative early-stage breast cancer will respond to immunotherapy drugs.
New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug, pembrolizumab, to chemotherapy before and after surgery for breast cancer
Genetic diversity of the malaria parasite in pregnant women and children declined in an area targeted for malaria elimination in Mozambique, according to a study